INS and Hepatic steatosis: In addition, we show that the effects of PLIN5 in BAT secondarily lead to smaller adipocytes in iWAT, to improved systemic glucose tolerance and insulin sensitivity, and to protection from hepatic steatosis on a high-fat diet (HFD).